Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Comparison of Demographic, Clinical, and Laboratory Characteristics Among Patients with Normal BMD, Osteopenia, and Osteoporosis Based on Lumbar Spine MeasurementsVariableNormal BMD(n = 1,338)Osteopenia(n = 809)Osteoporosis(n = 380)p-valueEffect sizeDemographic CharacteristicsAge (years)57.1 ± 12.5a59.6 ± 12.2b62.9 ± 10.6c < 0.0010.028Female877 (65.5%)a624 (77.1%)b331 (87.1%)c < 0.0010.180Smoking < 0.0010.072Current smoker209 (15.6%)a122 (15.1%)a35 (9.3%)bEx smoker274 (20.5%)a126 (15.6%)b54 (14.3%)bNon-smoker854 (63.9%)a558 (69.2%)b289 (76.5%)cBMI (kg/m2)31.4 ± 6.2a29.9 ± 6.1b28.1 ± 5.7c < 0.0010.037Duration of diabetes (months)150.2 ± 101.2a142.5 ± 102.4ab128.7 ± 97.2b0.0010.006Fracture history92 (6.9%)a70 (8.7%)ab68 (17.9%)bp < 0.0010.132Laboratory CharacteristicsA1C (%)8.2 ± 2.18.0 ± 2.08.2 ± 2.20.1000.002Creatinin (mg/dL)0.84 ± 0.350.83 ± 0.40.86 ± 0.490.5470.001Calcium (mg/dL)9.6 ± 0.5a9.6 ± 0.6a9.4 ± 0.7b < 0.0010.011Phosphorus (mg/dL)3.6 ± 0.63.6 ± 0.73.5 ± 0.70.0510.00225(OH)Vitamin D (ng/mL)20.8 ± 11.620.9 ± 12.121.1 ± 12.90.9180.001PTH (pg/mL)50.6 ± 32.4a55.4 ± 50.1ab60.4 ± 50.4b < 0.0010.007TSH (mIU/L)2.1 ± 2.12.0 ± 1.71.9 ± 1.80.0940.002Total cholesterol (mg/dL)191.6 ± 47.5195.1 ± 46.6192.8 ± 410.2480.001HDL cholesterol (mg/dL)48.4 ± 12.9a50.9 ± 14.7b49.6 ± 14.4ab < 0.0010.006LDL cholesterol (mg/dL)113.3 ± 39.3115.8 ± 41.1112.8 ± 34.90.2920.001Triglyceride (mg/dL)179.8 ± 133.3174.9 ± 145.6166.1 ± 105.70.2050.001Antidiabetic drugsTZD use129 (9.6%)63 (7.8%)34 (8.9%)0.3510.029SGLT2 inhibitor use518 (38.7%)a262 (32.4%)b82 (21.6%)c < 0.0010.126Insulin use716 (53.6%)a382 (47.5%)b169 (44.6%)b0.0010.073Diabetic complicationsRetinopathy261 (19.6%)125 (15.5%)66 (17.5%)0.0550.048Polyneuropathy416 (31.2%)232 (28.7%)130 (34.2%)0.1490.039Microalbuminuria278 (20.9%)ab141 (17.5%)b91 (24.2%)a0.0230.055Macroalbuminuria70 (5.3%)a44 (5.5%)ab33 (8.8%)b0.0300.053Coronary artery disease273 (20.4%)153 (18.9%)80 (21.1%)0.6080.020Cerebrovascular disease36 (2.7%)33 (4.1%)8 (2.1%)0.0980.043Peripheral arterial disease21 (1.6%)15 (1.9%)5 (1.3%)0.7710.014Hypertension716 (53.6%)418 (51.7%)189 (49.9%)0.3850.028BMD, bone mineral density; BMI, body mass index; A1c, hemoglobin A1c; PTH, parathyroid hormone; TSH, thyroid-stimulating hormone; HDL, high-density lipoprotein; LDL, low density lipoprotein; TZD, thiazolidinedione; SGLT2, sodium-glucose cotransporter-2abc The superscripts show the results of pairwise comparisons using the Bonferroni test between groups; values with unlike letters were significantly different among groups.
Source: Prevalence and determinants of low BMD. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
BMD was assessed using dual-energy X-ray absorptiometry (DXA) and fracture risk was estimated via the Turkish-adapted FRAX® algorithm in patients aged ≥ 40 years.
Source: Abstract.
This multicenter, retrospective, cross-sectional study was conducted between October 2023 and April 2024 across 27 endocrinology centers representing all major geographical regions of Türkiye.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Bone health and fracture risk in diabetes: A multicenter study
Cross-sectional study · Archives of Osteoporosis · 2026
Original publication title
Bone health and fracture risk in diabetes: A multicenter study
© The Author(s) 2026
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To evaluate bone health, including osteopenia, osteoporosis, and fracture risk, in adults with T1DM and T2DM.
Source: ObjectiveAbstract: What methods does the paper describe?
This multicenter, cross-sectional study included 2562 patients (224 with T1DM, 2338 with T2DM) from 27 centers across Türkiye. BMD was assessed using dual-energy X-ray absorptiometry (DXA) and fracture risk was estimated via the Turkish-adapted FRAX® algorithm in patients aged ≥ 40 years. Multinomial logistic regression was used to identify independent predictors of low BMD.
Source: MethodsAbstract: Summary
We assessed bone health in over 2500 adults with diabetes across Türkiye. T1DM patients had lower BMD, while T2DM patients showed higher fracture risk despite higher BMD. Several modifiable factors were linked to osteoporosis. These findings support personalized bone assessments in diabetic populations.
Source: SummaryAbstract: Results
Osteoporosis prevalence was 5.5% in T1DM and 9.6% in T2DM (femoral neck T-score). Adjusted BMD was significantly lower in T1DM at all skeletal sites, while FRAX-based fracture risk and fall-related fractures were higher in T2DM. Independent predictors of osteoporosis included older age, female sex, lower BMI, reduced calcium levels, corticosteroid use, albuminuria, hypertension, and less frequent sodium-glucose cotransporter-2 (SGLT2) inhibitor use. T1DM was independently associated with osteopenia but not osteoporosis.
Source: ResultsAbstract: Conclusion
This multicenter study demonstrates distinct patterns of BMD and fracture risk across diabetes subtypes and supports individualized bone health assessment in routine diabetes care.
Source: ConclusionAuthors’ abstract
Summary
We assessed bone health in over 2500 adults with diabetes across Türkiye. T1DM patients had lower BMD, while T2DM patients showed higher fracture risk despite higher BMD. Several modifiable factors were linked to osteoporosis. These findings support personalized bone assessments in diabetic populations.
Background
Diabetes mellitus (DM) is a recognized risk factor for bone fragility. While type 1 DM (T1DM) is typically associated with low bone mineral density (BMD), type 2 DM (T2DM) often presents with higher BMD despite increased fracture risk. Large-scale comparative studies remain limited.
Objective
To evaluate bone health, including osteopenia, osteoporosis, and fracture risk, in adults with T1DM and T2DM.
Methods
This multicenter, cross-sectional study included 2562 patients (224 with T1DM, 2338 with T2DM) from 27 centers across Türkiye. BMD was assessed using dual-energy X-ray absorptiometry (DXA) and fracture risk was estimated via the Turkish-adapted FRAX® algorithm in patients aged ≥ 40 years. Multinomial logistic regression was used to identify independent predictors of low BMD.
Results
Osteoporosis prevalence was 5.5% in T1DM and 9.6% in T2DM (femoral neck T-score). Adjusted BMD was significantly lower in T1DM at all skeletal sites, while FRAX-based fracture risk and fall-related fractures were higher in T2DM. Independent predictors of osteoporosis included older age, female sex, lower BMI, reduced calcium levels, corticosteroid use, albuminuria, hypertension, and less frequent sodium-glucose cotransporter-2 (SGLT2) inhibitor use. T1DM was independently associated with osteopenia but not osteoporosis.
Conclusion
This multicenter study demonstrates distinct patterns of BMD and fracture risk across diabetes subtypes and supports individualized bone health assessment in routine diabetes care.
Publication and source details
Original title: Bone health and fracture risk in diabetes: A multicenter study
Özen Öz Gül; Zeynep Cantürk; Sadettin Öztürk; Nilüfer Özdemir; Dilek Kılınç Candemir; Burak Özbaş; Filiz Mercantepe; Filiz Mercan Sarıdaş; Erhan Hocaoğlu; Onur Elbasan; Burcu Candemir; Berrin Çetinarslan; Ali Saklamaz; Şerife Ezgi Doğan; Elif Seray Korkmaz; Sezin Doğan Çakır; Hülya Kaynak; Emine Kartal Baykan; Mehmet Güven; Murat Çalapkulu; Onur Daloğlu; Yasemin Aydoğan Ünsal; Özlem Kanburoğlu; Selin Çakmak Demir; Dilek Gogas Yavuz; Zeynep Çetin; Ayşen Akkurt Kocaeli; Zeliha Hekimsoy; Mithat Mızrak; Zehra Candan; Erman Çakal; Gülce Ecem Kılıç; Göknur Yorulmaz; Mine Adaş; Zeliha Yarar; Pınar Akhanlı; Metin Güçlü; Muhammet Cüneyt Bilginer; Adnan Batman; Sevdenur Taşkın; Sema Hepşen; Aysen Akalın; Serpil Çiftel; Anna Abbasgholizadeh; Oğuzhan Deyneli; Zehra Erdemir; Gamze Gelir Çavdar; Yusuf Kayhan; Taner Bayraktaroğlu; Güven Özkaya
Archives of Osteoporosis · 2026
© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Bursa Uludag UniversityOpen access funding provided by the Scientific and Technological Research Council of Türkiye (TÜBİTAK).
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:02:26.363301+00:00
DOI: 10.1007/s11657-026-01667-z · PMC12909314